In the present report, we robustly demonstrated the significantly up-regulated expression of SLC35A2 in STAD tissues compared with normal tissues, meanwhile, it was related to a worse prognosis in STAD patients. Here, SLC35A2 is linked to gastric adenocarcinoma.